ARCHIVES

FDA’s Commitment To Cancer No Different Than Other Diseases, Kessler Tells Advocate

This article is from The Cancer Letter archive.

Vol. 18 No. 33 | August 14, 1992

Download PDF Visit The Full Archive

Related Articles

NCAB Working Group Renamed, Adds Karen Antman

December 16, 1994

Zaltrap Price Cut In Half Effective Immediately

November 8, 2012

Research Base Would Be Increased In Guideline Change

November 9, 1990

NCI Programs: Advisors Approve Plans For New Grants In Imaging Research

July 10, 1998

Impath Buys Clinical Studies Support Services Network.

September 28, 2001

Broder Says No Thanks To Acknowledgement For Paper’s Title

June 6, 1997